HKD 0.08
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 223.82 Million HKD | -17.64% |
2022 | 271.77 Million HKD | -20.38% |
2021 | 341.34 Million HKD | 7.48% |
2020 | 317.57 Million HKD | -35.12% |
2019 | 489.45 Million HKD | -21.01% |
2018 | 619.67 Million HKD | -14.05% |
2017 | 720.95 Million HKD | 20.74% |
2016 | 597.12 Million HKD | 39.1% |
2015 | 429.27 Million HKD | -58.27% |
2014 | 1.02 Billion HKD | -5.27% |
2013 | 1.08 Billion HKD | 30.73% |
2012 | 830.65 Million HKD | -2.85% |
2011 | 854.99 Million HKD | 24.82% |
2010 | 684.95 Million HKD | 91.65% |
2009 | 357.4 Million HKD | -16.04% |
2008 | 425.67 Million HKD | 86.44% |
2007 | 228.31 Million HKD | 2.18% |
2006 | 223.44 Million HKD | -3.24% |
2005 | 230.92 Million HKD | 30.17% |
2004 | 177.39 Million HKD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 200.32 Million HKD | 0.0% |
2023 Q4 | 223.82 Million HKD | 0.0% |
2023 FY | 223.82 Million HKD | -17.64% |
2023 Q2 | 223.13 Million HKD | 0.0% |
2022 FY | 271.77 Million HKD | -20.38% |
2022 Q2 | 303.94 Million HKD | 0.0% |
2022 Q4 | 271.77 Million HKD | 0.0% |
2021 Q4 | 341.34 Million HKD | 0.0% |
2021 FY | 341.34 Million HKD | 7.48% |
2021 Q2 | 302.84 Million HKD | 0.0% |
2020 FY | 317.57 Million HKD | -35.12% |
2020 Q2 | 261.26 Million HKD | 0.0% |
2020 Q4 | 317.57 Million HKD | 0.0% |
2019 FY | 489.45 Million HKD | -21.01% |
2019 Q4 | 489.45 Million HKD | 0.0% |
2019 Q2 | 508.02 Million HKD | 0.0% |
2018 Q4 | 619.67 Million HKD | 0.0% |
2018 FY | 619.67 Million HKD | -14.05% |
2018 Q2 | 753.47 Million HKD | 0.0% |
2017 FY | 720.95 Million HKD | 20.74% |
2017 Q2 | 625.52 Million HKD | 0.0% |
2017 Q4 | 720.95 Million HKD | 0.0% |
2016 FY | 597.12 Million HKD | 39.1% |
2016 Q4 | 597.12 Million HKD | 0.0% |
2016 Q2 | 529.67 Million HKD | 0.0% |
2015 Q2 | 232.18 Million HKD | 0.0% |
2015 Q4 | 429.27 Million HKD | 0.0% |
2015 FY | 429.27 Million HKD | -58.27% |
2014 Q2 | 1.12 Billion HKD | 0.0% |
2014 Q4 | 1.02 Billion HKD | 0.0% |
2014 FY | 1.02 Billion HKD | -5.27% |
2013 Q2 | 1.01 Billion HKD | 0.0% |
2013 FY | 1.08 Billion HKD | 30.73% |
2013 Q4 | 1.08 Billion HKD | 0.0% |
2012 FY | 830.65 Million HKD | -2.85% |
2012 Q2 | 947.62 Million HKD | 0.0% |
2012 Q4 | 830.65 Million HKD | 0.0% |
2011 Q2 | 845.42 Million HKD | 0.0% |
2011 FY | 854.99 Million HKD | 24.82% |
2011 Q4 | 854.99 Million HKD | 0.0% |
2010 Q4 | 684.95 Million HKD | 0.0% |
2010 FY | 684.95 Million HKD | 91.65% |
2010 Q2 | 638.06 Million HKD | 0.0% |
2009 Q4 | 357.4 Million HKD | 0.0% |
2009 FY | 357.4 Million HKD | -16.04% |
2009 Q2 | 428.66 Million HKD | 0.0% |
2008 Q4 | 425.67 Million HKD | 0.0% |
2008 FY | 425.67 Million HKD | 86.44% |
2007 FY | 228.31 Million HKD | 2.18% |
2006 FY | 223.44 Million HKD | -3.24% |
2005 FY | 230.92 Million HKD | 30.17% |
2004 FY | 177.39 Million HKD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aidigong Maternal & Child Health Limited | 1.2 Billion HKD | 81.413% |
UMP Healthcare Holdings Limited | 362.14 Million HKD | 38.195% |
Human Health Holdings Limited | 289.7 Million HKD | 22.742% |
EuroEyes International Eye Clinic Limited | 588.09 Million HKD | 61.941% |
Kato (Hong Kong) Holdings Limited | 428.77 Million HKD | 47.799% |
Bamboos Health Care Holdings Limited | 99.73 Million HKD | -124.415% |
C-MER Eye Care Holdings Limited | 755.34 Million HKD | 70.368% |
Town Health International Medical Group Limited | 881.82 Million HKD | 74.618% |
Medicskin Holdings Limited | 32.47 Million HKD | -589.131% |
Hang Chi Holdings Limited | 100.92 Million HKD | -121.763% |